FDA Adverse Event Malfunction Summary report: N

NOVOLOG FLEXPEN

MDR report key: 13175470 · Received January 6, 2022

Report

Report Number
13175470
Event Type
Malfunction
Date Received
January 6, 2022
Date of Event
December 15, 2021
Report Date
December 20, 2021
Manufacturer
BECTON DICKINSON PEN LIMITED
Product Code
FMI
Product Problem
Yes
Report Source
User Facility report
Reporter Location
MN
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Description of Event or Problem · 0

NURSING BROUGHT GLARGINE INSULIN PEN TO PHARMACY, NOTING THAT IT WAS DIFFICULT TO ADMINISTER INSULIN THROUGH. UPON INSPECTION, IT APPEARS THAT THE SYRINGE WAS COMPLETELY FULL AND NO INSULIN HAD BEEN ADMINISTERED OUT OF IT OVER THE PAST 4 DAYS (WAS DISPENSED AT 0941). THERE WAS WHAT IS PRESUMED TO BE A PIECE OF THE PEN NEEDLE STUCK IN THE SYRINGE HUB, WHICH WOULDN'T ALLOW INSULIN TO MOVE THROUGH BUT WOULD ALLOW THE SYRINGE TO BE DEPRESSED. PHARMACY DISPOSED OF THE SYRINGE AND SENT A NEW ONE TO NURSE. LANTUS LOT: 1F7979A, NEEDLE LOT: 1134014. SANOFI MAKES THE INSULIN (LANTUS) AND THE PEN NEEDLE MANUFACTURER IS BD. NO PATIENT HARM, GLUCOSE SLIGHTLY ELEVATED AS A RESULT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
31862 NOVOLOG FLEXPEN NEEDLE, HYPODERMIC, SINGLE LUMEN FMI BECTON DICKINSON PEN LIMITED 1134014

Patients

Seq Age Sex Outcome Treatment
1 21535 DA Female